{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:20:04Z","timestamp":1782184804945,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":2407,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 DK090209"],"award-info":[{"award-number":["K23 DK090209"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1111\/ajt.13620","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T01:25:43Z","timestamp":1448414743000},"page":"1588-1595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"title":["Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents"],"prefix":"10.1016","volume":"16","author":[{"given":"D.","family":"Sawinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ajeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Trofe-Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Goral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Forde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.13620_bib1","first-page":"249","article-title":"Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Recent evidence","volume":"56","author":"Fabrizi","year":"2004","journal-title":"Minerva Urol Nefrol"},{"key":"10.1111\/ajt.13620_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/ajkd.2001.21294","article-title":"Serum alanine aminotransferase in hepatitis C screening of patients on hemodialysis","volume":"37","author":"Saab","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.13620_bib3","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1046\/j.1523-1755.1998.00883.x","article-title":"Effect of hepatitis C infection and renal transplantation on survival in end state renal disease","volume":"53","author":"Pereira","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13620_bib4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1681\/ASN.2010060668","article-title":"Effect of kidney transplantation on outcomes among patients with hepatitis C","volume":"22","author":"Roth","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13620_bib5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0b013e3181f92548","article-title":"Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand","volume":"90","author":"Scott","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13620_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/TP.0b013e318225dbae","article-title":"Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: Data from the RESITRA\/REIPI cohort","volume":"92","author":"Lopez-Medrano","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13620_bib7","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/ndt\/16.8.1669","article-title":"Risk of death and liver cirrhosis in anti-HCV postive long term hemodialysis patients","volume":"16","author":"Espinosa","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.13620_bib8","doi-asserted-by":"crossref","first-page":"137480","DOI":"10.1097\/01.ASN.0000012382.97168.E0","article-title":"Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus","volume":"13","author":"Bloom","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13620_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ki.2011.194","article-title":"Overlapping pathways to transplant glomerulopathy: Chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy","volume":"80","author":"Baid-Agrawal","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13620_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-6143.2001.10212.x","article-title":"Hepatitis C virus infection and de novo glomerular lesions in renal allografts","volume":"1","author":"Cruzado","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13620_bib11","first-page":"CD007003","article-title":"Interventions for dialysis patients with hepatitis C virus (HCV) infection","volume":"8","author":"Prabhu","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ajt.13620_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jvh.12276","article-title":"Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: Meta-analysis of clinical studies","volume":"21","author":"Fabrizi","year":"2014","journal-title":"J Viral Hepatitis"},{"key":"10.1111\/ajt.13620_bib13","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1572-0241.2003.07526.x","article-title":"Interferon monotherapy for dialysis patient with chronic hepatitis C: An analysis of the literature on efficacy and safety","volume":"98","author":"Russo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/ajt.13620_bib14","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1097\/01.ASN.0000079613.81511.3C","article-title":"Evidence that clearance of hepatitis C virus RNA after a-interferon therapy in dialysis patients is sustained after renal transplantation","volume":"14","author":"Kamar","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13620_bib15","doi-asserted-by":"crossref","first-page":"35756","DOI":"10.1034\/j.1600-6143.2003.00057.x","article-title":"Pretransplant interferon prevents hepatitis C virus associated glomerulonephritis in renal allografts by HCV-RNA clearance","volume":"3","author":"Cruzado","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13620_bib16","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1093\/ndt\/10.11.2104","article-title":"Recombinant alpha interferon in renal allograft recipients with chronic hepatitis C","volume":"10","author":"Ozgur","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.13620_bib17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13620_bib18","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/ki.2008.87","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Guideline 4: Management of HCV-infected patients before and after kidney transplantation","volume":"73","year":"2008","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13620_bib19","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(14)61036-9","article-title":"Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: The COSMOS randomised study","volume":"384","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"key":"10.1111\/ajt.13620_bib20","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13620_bib21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ajg.2014.66","article-title":"The rapid evolution of treatment strategies for hepatitis C","volume":"109","author":"Muir","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/ajt.13620_bib22","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An Interferon-free Antiviral Regimen for HCV after Liver Transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13620_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplant","volume":"148","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.13620_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/lt.24126","article-title":"Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients","volume":"21","author":"Gutierrez","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13620_bib25","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-na\u00efve and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease","volume":"386","author":"Roth","year":"2015","journal-title":"Lancet"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13620","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522008541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522008541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:11:24Z","timestamp":1761628284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522008541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1600613522008541"],"URL":"https:\/\/doi.org\/10.1111\/ajt.13620","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.13620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}